Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Joseph Harvey

London
As Editor of Animal Pharm, Joseph Harvey provides news and analysis about the global animal health market across a range of species and products. He conducts exclusive interviews with the sector's biggest companies and experts, as well as start-up firms. He also hosts webinars and gives speeches on the industry.

Having gained many years' experience in business journalism, Joseph joined Informa in 2007, reporting on the medical technology space. He joined Animal Pharm, rising to become editor and taking the publication online only.

Joseph also launched a series of well-received webinars. As author of a top-selling industry report, he detailed the leading companies in the animal health sector. Since becoming editor, he has transformed Animal Pharm from just a news provider into a more in-depth analytical service.
Set Alert for Articles By Joseph Harvey

Latest From Joseph Harvey

New research highlights worst-case ASF scenario for US

Research has suggested a potential outbreak of African swine fever (ASF) could have a USD50 billion impact on the US swine industry across 10 years.

United States Hogs & Pork

Kane benefits from Dechra relationship as 2019 closes with strong Q4 growth

Kane Biotech reported a 259% upturn in revenues during the fourth quarter of 2019.

Financial Results

University highlights worst-case ASF scenario for US

Research has suggested a potential outbreak of African swine fever (ASF) could have a $50 billion impact on the US swine industry across 10 years.

United States Porcine

Chanelle secures FDA approval for selamectin-based generic

Ireland's Chanelle has gained US FDA authorization for a generic companion animal topical antiparasitic.

Product Approvals Antiparasitics

Italian firm signs CRISPR/Cas9 pact to boost animal health discovery services

Italy's Axxam has gained access to the CRISPR-Cas9 patent portfolio developed by Irish company ERS Genomics.

Deals R&D

Kleber Gomes becomes head of Ouro Fino after chief executive resignation

Brazil's Ouro Fino Saúde Animal has a new chief executive after Jardel Massari stepped down from the role. 

Ouro Fino Saude Animale People
See All
UsernamePublicRestriction

Register